EssilorLuxotticaESLOYPAST TOP PICKFeb 24, 2025Stock price when the opinion was issued
As of Sep 16, 2026. Market Open.
Lenses + Frames. 800-pound gorilla in eyecare throughout the world. Valuation is in very interesting territory. Tariffs, exchange rates, Ray-Ban smart glasses under pressure. Long-term demographics of people needing corrective lenses mean it's well-positioned. (Price target in euros.) Yield is 2.80%.
(Analysts’ price target is $238.90)Doesn't like META, but a way around that is to own this name instead. Makes the virtual reality glasses for META. Essilor does the lenses, and Luxottica does the frames. Less volatility. Up this year ~48-49%.
Shows that you don't have to own the big names. You can own names that have access to what's happening in AI and virtual reality, diversify your portfolio, and lessen the volatility risk.
Lenses plus frames. Has a lock on the whole value chain. Purchase of Grant Vision will dramatically change its business over the next several years. Use of lenses has increased because of aging demographics plus faster eye deterioration from computer screens. Also a fashion statement. Great technology. Yield is 1.7%.
(Analysts’ price target is $109.40)
It is a framing business for eye wear. People need more glasses due to so much computer use which can affect the eyes. Also includes frames for fashionable sunglasses etc. There is lots of growth.